Insofar as RBM3 knockdown appeared to recapitulate several aspects of MAT exhibited by mesenchymal cancer cells, our data may also help inform on the mechanistic significance of correlations between RBM3 expression level and both the metastatic potential and clinical outcome of many cancers. This evidence concerns the gene RBM3 and cancer.